GGrantIndex
← Search

HYDROXYUREA &IN COMBINATION W/ DDI VS DDI IN HIV INFECTION

$0M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Abstract

The purpose of this study is to test the safety of two doses of a drug, hydroxyurea, given alone or in combination with another drug, ddI, in HIV-infected persons, and to see if hydroxyurea given alone or in combination with ddI decreaes the amount of virus in the blood of HIV-infected persons as compared to ddI given alone.

View original record on NIH RePORTER →